EW:NYSE
Edwards Lifesciences Corp
85,19Â USD
arrow_downward
−1,31%(−1,13) 1 D
85,19Â USD
0,00% (0,00)
bedtimeEtter stengetid
Stengt: 1. okt., 16:00:04 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for EW …
Ã…pne
85,99Â USD
Høy
86,84Â USD
Lav
84,48Â USD
Markedsverdi
49,10Â mrd.
Snittvolum
3,24Â mill.
Volum
0,00
P/E-forhold
49,29
52 u høy
96,29Â USD
52Â u lav
72,30Â USD
EPS
1,73Â USD
Beta
0,85
Utestående aksjer
576,40Â mill.
Antall ansatte
16k
Ã…pne
85,99Â USD
Høy
86,84Â USD
Lav
84,48Â USD
Markedsverdi
49,10Â mrd.
Snittvolum
3,24Â mill.
Volum
0,00
P/E-forhold
49,29
52 u høy
96,29Â USD
52Â u lav
72,30Â USD
EPS
1,73Â USD
Beta
0,85
Utestående aksjer
576,40Â mill.
Antall ansatte
16k
Nyhetssaker
Fra nettkilder og nyhetspartnere
News Corp
·
for 9 timer siden
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day
AD HOC NEWS
·
for 15 timer siden
Wall Street Zen downgrades Edwards Lifesciences stock to Hold
Profil
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Om Edwards Lifesciences Corp
Administrerende direktør-
Ansatte16k
Grunnlagt1958
HovedkontorIrvine, California, USA
Sektor-
Nettstededwards.com